| | TEMAZEPAM-D5 Basic information |
| Product Name: | TEMAZEPAM-D5 | | Synonyms: | TEMAZEPAM-D5;2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-(phenyl-d5)-;TEMAZEPAM-D5,100/MLINMETHANOL;Temazepam-d5 solution;Temazepam-d5 (CRM);7-chloro-3-hydroxy-1-methyl-5-(2,3,4,5,6-pentadeuteriophenyl)-3H-1,4-benzodiazepin-2-one;Temazepam-d5 (phenyl-d5);[2H5]-Temazepam, racemic mixture | | CAS: | 136765-51-0 | | MF: | C16H8ClD5N2O2 | | MW: | 305.77 | | EINECS: | 803-032-0 | | Product Categories: | | | Mol File: | 136765-51-0.mol |  |
| | TEMAZEPAM-D5 Chemical Properties |
| | TEMAZEPAM-D5 Usage And Synthesis |
| Description | Temazepam-d5 (Item No. 15859) is an analytical reference material intended for use as an internal standard for the quantification of temazepam . Temazepam is categorized as a benzodiazepine. Temazepam has sedative-hypnotic properties and misuse via intra-arterial injection has been associated with tissue damage and subsequent amputation. Temazepam-d5 is regulated as a Schedule IV compound in the United States. This product is intended for research and forensic applications. | | Uses | Temazepam (Phenyl D5) is labelled Temazepam (T017200) which is an intermediate-acting 3-hydroxy hypnotic of the benzodiazepine class of psychoactive drugs. Temazepam has anxiolytic (anti-anxiety), anticonvulsant, and skeletal muscle relaxant properties. | | References | [1] SHANLIN FU. Reduction of temazepam to diazepam and lorazepam to delorazepam during enzymatic hydrolysis[J]. Analytical and Bioanalytical Chemistry, 2011, 400 1: 153-164. DOI: 10.1007/s00216-011-4723-y
[2] D.M. NOTT . Intra-arterial injection of temazepam in drug abusers[J]. European journal of vascular surgery, 1993, 7 1: Pages 87-89. DOI: 10.1016/s0950-821x(05)80550-x
[3] GERALD FX FEENEY MB BCH BAO FRACP Harry H G M B F. Digit loss following misuse of temazepam[J]. Medical Journal of Australia, 2002, 176 8: 380. DOI: 10.5694/j.1326-5377.2002.tb04460.x |
| | TEMAZEPAM-D5 Preparation Products And Raw materials |
|